- Home
- EBON vs THAR Comparison
EBON vs THAR Comparison
Compare EBON & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- THAR
- Stock Information
- Founded
- EBON 2010
- THAR 2017
- Country
- EBON China
- THAR United States
- Employees
- EBON N/A
- THAR N/A
- Industry
- EBON Semiconductors
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- THAR Health Care
- Exchange
- EBON Nasdaq
- THAR Nasdaq
- Market Cap
- EBON 24.4M
- THAR 22.8M
- IPO Year
- EBON 2020
- THAR 2022
- Fundamental
- Price
- EBON $4.15
- THAR $3.92
- Analyst Decision
- EBON
- THAR Strong Buy
- Analyst Count
- EBON 0
- THAR 1
- Target Price
- EBON N/A
- THAR $17.00
- AVG Volume (30 Days)
- EBON 10.8K
- THAR 3.2M
- Earning Date
- EBON 08-15-2025
- THAR 11-07-2025
- Dividend Yield
- EBON N/A
- THAR N/A
- EPS Growth
- EBON N/A
- THAR N/A
- EPS
- EBON N/A
- THAR N/A
- Revenue
- EBON $7,337,066.00
- THAR N/A
- Revenue This Year
- EBON N/A
- THAR N/A
- Revenue Next Year
- EBON N/A
- THAR N/A
- P/E Ratio
- EBON N/A
- THAR N/A
- Revenue Growth
- EBON 104.28
- THAR N/A
- 52 Week Low
- EBON $3.00
- THAR $0.95
- 52 Week High
- EBON $10.94
- THAR $9.08
- Technical
- Relative Strength Index (RSI)
- EBON 43.67
- THAR 55.08
- Support Level
- EBON $4.05
- THAR $2.85
- Resistance Level
- EBON $4.49
- THAR $5.27
- Average True Range (ATR)
- EBON 0.27
- THAR 0.73
- MACD
- EBON -0.03
- THAR 0.11
- Stochastic Oscillator
- EBON 20.55
- THAR 21.14
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.